Latest filing published 14 Oct 2020 for Aimmune Therapeutics, Inc., €1.4M.
This profile gathers the share dealings of Douglas T. Sheehy across 2 companies, led by Aimmune Therapeutics, Inc. and Codexis, Inc. Over a trading history stretching from 10 February 2016 to 13 October 2020, the count stands at 49 filings.
On the market, this insider has only sold: 20 sales, €2.5M in total. The rest of the record consists of 11 share grants and 16 option exercises. In 2020 alone, the filings show no purchases and 1 sale.
The latest filing, published on 14 October 2020, reports a transaction of €1.4M in Aimmune Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations